Long‐term effects of asparaginase‐associated pancreatitis
Open Access
- 28 June 2023
- journal article
- editorial
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 70 (9) , e30528
Abstract
Pancreatitis is a common and severe toxicity that occurs during asparaginase treatment for acute lymphoblastic leukemia, and has received increasing attention during the last decades. However, no consensus regarding follow‐up exists. In this commentary, we highlight potential long‐term health‐related effects following asparaginase‐associated pancreatitis, thereby providing clinicians with a framework when following these patients during and after cessation of therapy.Keywords
Funding Information
- Børnecancerfonden ((2017–2082;2019–5966,2020‐6737,2022‐8161))
- Aarhus Universitet
This publication has 39 references indexed in Scilit:
- Asparaginase‐associated pancreatitis in childrenBritish Journal of Haematology, 2012
- Health‐related Quality of Life in Pediatric Patients With Long‐standing PancreatitisJournal of Pediatric Gastroenterology and Nutrition, 2012
- Cytokines and Organ Failure in Acute PancreatitisPancreas, 2012
- Acute Pancreatitis in Children With Acute Lymphoblastic Leukemia Treated With L-AsparaginaseJournal of Pediatric Hematology/Oncology, 2009
- Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase‐associated pancreatitisPediatric Blood & Cancer, 2009
- Pancreatic pseudocystWorld Journal of Gastroenterology, 2009
- Predicting asparaginase‐associated pancreatitisPediatric Blood & Cancer, 2006
- Pathogenesis of Pain in Chronic PancreatitisDigestive Diseases, 2004
- Delayed puberty in chronic illnessBest Practice & Research Clinical Endocrinology & Metabolism, 2002
- Exocrine Pancreatic Function in the Early Phase of Human Acute PancreatitisScandinavian Journal of Gastroenterology, 1995